Evidence map›Paper›PMID 34511900›Full record

ReviewInternational journal of nanomedicine2021

Functionalized Graphene Platforms for Anticancer Drug Delivery.

Shabnam Sattari, Mohsen Adeli, Siamak Beyranvand, Mohammad Nemati

Open access · goldAbstract readReview
In one paragraph

Review in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Functionalized Nanomaterials in Cancer Treatment: A Review.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shabnam SattariDepartment of Chemistry, Faculty of Science, Lorestan University, Khorramabad, Iran.
Mohsen AdeliDepartment of Chemistry, Faculty of Science, Lorestan University, Khorramabad, Iran.
Siamak BeyranvandDepartment of Chemistry, Faculty of Science, Lorestan University, Khorramabad, Iran.ORCID 0000-0001-6168-8193
Mohammad NematiDepartment of Chemistry, Faculty of Science, Lorestan University, Khorramabad, Iran.
Lorestan University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional nanomaterials are emerging as promising candidates for a wide range of biomedical applications including tissue engineering, biosensing, pathogen incapacitation, wound healing, and gene and drug delivery. Graphene, due to its high surface area, photothermal property, high loading capacity, and efficient cellular uptake, is at the forefront of these materials and plays a key role in this multidisciplinary research field. Poor water dispersibility and low functionality of graphene, however, hamper its hybridization into new nanostructures for future nanomedicine. Functionalization of graphene, either by covalent or non-covalent methods, is the most useful strategy to improve its dispersion in water and functionality as well as processability into new materials and devices. In this review, recent advances in functionalization of graphene derivatives by different (macro)molecules for future biomedical applications are reported and explained. In particular, hydrophilic functionalization of graphene and graphene oxide (GO) to improve their water dispersibility and physicochemical properties is discussed. We have focused on the anticancer drug delivery of polyfunctional graphene sheets.

Indexed as

Antineoplastic AgentsGraphiteNanostructuresDrug Delivery SystemsNanomedicineAntineoplastic AgentsGraphiteanticancer drug deliveryfunctionalizationgraphenephotothermal therapytwo-dimensional nanomaterials

Identifiers

PMID34511900
PMCPMC8416335
OpenAlexW3196543867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.